The present study demonstrated that SOX17 was down-regulated during the progression of cervical cancer and that SOX17 expression inhibited the proliferation, tumor formation and activity of the Wnt/β-catenin signaling pathway by directly binding to the promoter region of β-catenin in cervical cancer cells. The gene discussed is SOX17; the disease is cervical carcinoma.